Guidelines and Consensus Statements

Section Edited by Robert L. Ferris, MD, PhD

Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel

Francesca Spada, Paolo Bossi, Corrado Caracò, Vanna Chiarion Sileni, Angelo Paolo Dei Tos, Nicola Fazio, Giovanni Grignani, Michele Maio, Pietro Quaglino, Paola Queirolo, Paolo Antonio Ascierto, DELPHI Panel Members, GC Antonini Cappellini, L Antonuzzo, G Badalamenti, M Barberis, F Bassetto, R Berardi, A Berruti, A Bongiovanni, P Bonomo, L Borgognoni, V Borzillo, F Bruder, D Campana, F Consoli, A Cordova, R Depenni, AM Di Giacomo, G Fabbrocini, MC Fargnoli, V Ferraresi, F Ferrau, MT Fierro, M Gatti, F Gelsomino, D Giuffrida, P Graziano, C Gregorelli, M Guida, D Massi, R Mazzarotto, L Milesi, AM Minisini, F Morgese, P Muto, G Palmieri, R Patuzzo, G Pellacani, F Picciotto, J Pigozzo, N Pimpinelli, P Poletti, L Repetto, G Rinaldi, P Rubegni, G Rubino, F Spagnolo, L Tagliaferri, E Tanda, MC Tronconi, M Tucci, M Valente, B Vincenzi, I Zalaudek

10.1136/jitc-2022-004742

June 14, 2022

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma

Ramaswamy Govindan, Charu Aggarwal, Scott J Antonia, Marianne Davies, Steven M Dubinett, Andrea Ferris, Patrick M Forde, Edward B Garon, Sarah B Goldberg, Raffit Hassan, Matthew D Hellmann, Fred R Hirsch, Melissa L Johnson, Shakun Malik, Daniel Morgensztern, Joel W Neal, Jyoti D Patel, David L Rimm, Sarah Sagorsky, Lawrence H Schwartz, Boris Sepesi, Roy S Herbst

10.1136/jitc-2021-003956

May 31, 2022

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma

Tim F Greten, Ghassan K Abou-Alfa, Ann-Lii Cheng, Austin G Duffy, Anthony B. El-Khoueiry, Richard S Finn, Peter R Galle, Lipika Goyal, Aiwu Ruth He, Ahmed O Kaseb, Robin Kate Kelley, Riccardo Lencioni, Amaia Lujambio, Donna Mabry Hrones, David J Pinato, Bruno Sangro, Roberto I Troisi, Andrea Wilson Woods, Thomas Yau, Andrew X Zhu, Ignacio Melero

10.1136/jitc-2021-002794

September 12, 2021

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors

Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Teilo H Schaller, Anthony A Amato, Allison Betof Warner, Priscilla K Brastianos, Tracey A Cho, Stacey L Clardy, Justine V Cohen, Jorg Dietrich, Michael Dougan, Christopher T Doughty, Divyanshu Dubey, Jeffrey M Gelfand, Jeffrey T Guptill, Douglas B Johnson, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Jenny Linnoila, Andrew L Mammen, Maria Martinez-Lage, Meghan J Mooradian, Jarushka Naidoo, Tomas G Neilan, David A Reardon, Krista M Rubin, Bianca D Santomasso, Ryan J Sullivan, Nancy Wang, Karin Woodman, Leyre Zubiri, William C Louv, Kerry L Reynolds

10.1136/jitc-2021-002890

July 19, 2021

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Jill Brufsky, Laura C Cappelli, Frank B Cortazar, David E Gerber, Lamya Hamad, Eric Hansen, Douglas B Johnson, Mario E Lacouture, Gregory A Masters, Jarushka Naidoo, Michele Nanni, Miguel-Angel Perales, Igor Puzanov, Bianca D Santomasso, Satish P Shanbhag, Rajeev Sharma, Dimitra Skondra, Jeffrey A Sosman, Michelle Turner, Marc S Ernstoff

10.1136/jitc-2021-002435

June 25, 2021